Eli Lilly comes for knockoff weight loss drugs in new ad campaignByBruce GilPublishedFebruary 28, 2025
Eli Lilly's big investment, cheaper Zepbound, and what's next for Hims & Hers: Pharma news roundupByBruce GilPublishedFebruary 28, 2025
Eli Lilly wants to make drugs in America. First it wants a tax cutByBruce GilPublishedFebruary 27, 2025
Hims & Hers can't sell off-brand Ozempic forever. But it can still sell these weight loss drugsByBruce GilUpdatedFebruary 25, 2025
A recall of supplemental shakes over listeria fears is linked to 12 deathsByBruce GilPublishedFebruary 25, 2025
Hims & Hers will stop selling some weight loss drugs — and the stock plummets 27%ByBruce GilUpdatedFebruary 25, 2025
Theranos founder Elizabeth Holmes' fraud conviction is upheld by an appeals courtByBruce GilPublishedFebruary 24, 2025
Disney and Warner Bros. Discovery could overtake Netflix. Here’s howByBruce GilPublishedFebruary 24, 2025
